Systemic AL amyloidosis associated with multiple myeloma in a horse.

This research chronicles the study of a 16-year-old horse diagnosed with systemic AL amyloidosis (a rare disease in animals but common in humans) associated with multiple myeloma. This is the first reported case of such a combination in domestic animals.

About the Research

• The paper talks about a particular case of a 16-year-old Quarter horse, diagnosed with systemic AL amyloidosis associated with multiple myeloma, a disease abnormality quite frequent in humans, but quite rare in domestic animals.
• The medical conditions observed in the horse included rapid weight loss, muscle atrophy, soft unformed stool, and ventral edema, which prompted the researchers to investigate further.

Findings and Observations

• A thorough examination revealed diffuse gastrointestinal hemorrhage, markedly thickened jejunal mucosa, and splenomegaly. Diffuse severe amyloid deposits were found in the lamina propria of the glandular stomach, duodenum, and jejunum.
• Most of the spleen and sternal bone marrow were replaced by neoplastic round cells, with multiple foci of amyloid also present.
• Upon closer investigation through electron microscopy, the neoplastic round cells were determined to be of plasma cell origin, indicative of the presence of multiple myeloma.
• The amyloid displayed strong positive immunoreactivity with polyclonal anti-human immunoglobin lambda light-chain antisera. This affirms the diagnosis of AL amyloidosis, as this deposition is characteristic of the disease.

Significance of the Research

• This case study is significant and of particular interest as this is the second report describing systemic AL amyloidosis in domestic animals-associated plasma cell neoplasia.
• Furthermore, it is the first to be associated with multiple myeloma, similar to cases commonly observed in humans.
• This could pave the way for further exploratory studies on the incidence and treatment of such complex pathologies in domestic animals, improving their quality of life and expanding our understanding of these diseases.